Open AccessPhase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma
Author(s) -
Bert H. O’Neil,
Laura Williams Goff,
John S. Kauh,
Jonathan Strosberg,
Tanios BekaiiSaab,
Ruey-min Lee,
Aslamuzzaman Kazi,
Dominic T. Moore,
Maria Learoyd,
Richard M. Lush,
Saı̈d M. Sebti,
Daniel M. Sullivan
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d1bm-nh04
Subject(s) - selumetinib , hepatocellular carcinoma , protein kinase a , mek inhibitor , cancer research , medicine , mapk/erk pathway , mitogen activated protein kinase kinase , oncology , kinase , chemistry , biochemistry